CA3260571A1 - Composé benzothiazole et son utilisation - Google Patents

Composé benzothiazole et son utilisation

Info

Publication number
CA3260571A1
CA3260571A1 CA3260571A CA3260571A CA3260571A1 CA 3260571 A1 CA3260571 A1 CA 3260571A1 CA 3260571 A CA3260571 A CA 3260571A CA 3260571 A CA3260571 A CA 3260571A CA 3260571 A1 CA3260571 A1 CA 3260571A1
Authority
CA
Canada
Prior art keywords
benzothiazole compound
benzothiazole
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3260571A
Other languages
English (en)
Inventor
Yin JI
Xueping Wang
Hui Zhai
Original Assignee
Nanjing Reju Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanjing Reju Therapeutics Inc filed Critical Nanjing Reju Therapeutics Inc
Publication of CA3260571A1 publication Critical patent/CA3260571A1/fr
Pending legal-status Critical Current

Links

CA3260571A 2022-06-24 2023-06-21 Composé benzothiazole et son utilisation Pending CA3260571A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202210727253.3 2022-06-24

Publications (1)

Publication Number Publication Date
CA3260571A1 true CA3260571A1 (fr) 2025-10-30

Family

ID=

Similar Documents

Publication Publication Date Title
EP4101852A4 (fr) Composé de pyridopyrimidinone et son utilisation
EP4105211A4 (fr) Composés pyrimidohétérocycliques et leur application
EP4096651A4 (fr) Composés et leurs utilisations
EP4096664A4 (fr) Composés et leurs utilisations
EP4096668A4 (fr) Composés et leurs utilisations
EP4186894A4 (fr) Composé inhibiteur de fgfr et son utilisation
EP4247815A4 (fr) Composés et leurs utilisations
EP4151636A4 (fr) Composé pyrrolidine et son utilisation
EP4393511A4 (fr) Composé lipidique et son utilisation
EP4365170A4 (fr) Composé amide et son utilisation
AU2022300316A1 (en) Novel compounds and their use
EP4249476A4 (fr) Sel de composé benzothiazole, forme cristalline et son utilisation
EP4338737A4 (fr) Inhibiteur de parp7 et son utilisation
EP4337211A4 (fr) Composés et leurs utilisations
CA3260571A1 (fr) Composé benzothiazole et son utilisation
CA3295659A1 (fr) Composé et son utilisation
HK40130291A (en) Compound and use thereof
CA3249979A1 (fr) Composé et son utilisation
HK40117316A (en) Compound and use thereof
HK40102139A (en) Heteroaryl-3-piperidinedione compound and use thereof
AU2021219489A1 (en) Compound and use thereof
CA3283630A1 (fr) Composé hétérocyclique et son utilisation
HK40126867A (en) Heterocyclic compound and use thereof
CA3274147A1 (fr) Composé hétérocyclique et son utilisation
CA3269972A1 (fr) Composés et leur utilisation